# Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata

> **NCT01167946** · PHASE4 · COMPLETED · sponsor: **King Saud University** · enrollment: 42 (actual)

## Conditions studied

- Alopecia Totalis
- Alopecia Universalis
- Ophiasic Alopecia

## Interventions

- **DRUG:** methylprednisolone sodium succinate
- **DRUG:** methylprednisolone sodium succinate
- **DRUG:** methylprednisolone sodium succinate

## Key facts

- **NCT ID:** NCT01167946
- **Lead sponsor:** King Saud University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2009-12
- **Final completion:** 2010-07
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2010-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01167946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01167946, "Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01167946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*